CLINICAL_TRIALS
trial_result
· 2015-01-06
Clinical Trial Update: Safety and PK Study of BIBF 1120 in Japanese Patients With IPF [Phase 2]
Summary
A Phase 2 safety and pharmacokinetics study of Boehringer Ingelheim's BIBF 1120 (nintedanib) in Japanese patients with idiopathic pulmonary fibrosis has complet…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2015-01-06